| RS1837613320 |
RET
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS1837613489 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS183764569 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS183764694 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 62 |
| RS1837660523 |
RET
|
Health Risk |
Pathogenic |
— |
| RS183770014 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1A |
| RS183771956 |
BBS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome |
| RS1837729713 |
RET
|
Health Risk |
Likely pathogenic |
RET-related disorder, RET-related disorder |
| RS1837733068 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1837733775 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS183776114 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS183776349 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1837778621 |
RET
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS1837779952 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS183784665 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS183784857 |
SEC23B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type II |
| RS1837849183 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1837849469 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1837850102 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1837854100 |
RET
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 2 |
| RS183785901 |
TMEM216
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 2, Meckel syndrome |
| RS1837911590 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1837949550 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Basal cell carcinoma, susceptibility to |
| RS183799079 |
GPR179
|
Health Risk |
Conflicting classifications of pathogenicity |
GPR179-related disorder, Inborn genetic diseases |
| RS1837993502 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1837994023 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS183800704 |
CCDC180
|
Health Risk |
Conflicting classifications of pathogenicity |
Mycotic Aneurysm, Intracranial |
| RS1838016447 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal hypodysplasia/aplasia 1, Pheochromocytoma |
| RS183802802 |
FGF23
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumoral calcinosis, hyperphosphatemic |
| RS1838031568 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Turner syndrome, Gorlin syndrome |
| RS1838077833 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS183812420 |
PCK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Phosphoenolpyruvate carboxykinase deficiency, cytosolic |
| RS183812948 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS183814213 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive retinitis pigmentosa, Retinitis pigmentosa |
| RS183815209 |
ZNF407
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1838166153 |
COL5A1
|
Health Risk |
Pathogenic |
— |
| RS1838169083 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS183817000 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma, Renal hypodysplasia/aplasia 1 |
| RS1838178513 |
RET
|
Health Risk |
Likely pathogenic |
Hirschsprung disease, susceptibility to |
| RS1838178869 |
RET
|
Health Risk |
Likely pathogenic |
Hirschsprung disease, susceptibility to |
| RS1838178970 |
RET
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 2B, Multiple endocrine neoplasia type 2B |
| RS183819382 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS183820888 |
MBD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1838244110 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1838244368 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1838252619 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1838279783 |
SLC18A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS183828175 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2N, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1838287933 |
ARFGEF1
|
Health Risk |
Pathogenic |
Global developmental delay, Delayed speech and language development |
| RS1838291478 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS183829292 |
DLAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E2 deficiency, Pyruvate dehydrogenase E2 deficiency |
| RS1838303339 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1838303542 |
PTCH1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1838305772 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1838307047 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1838315058 |
PTCH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS183834387 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS183837448 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1838374810 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 2A, Multiple endocrine neoplasia type 2B |
| RS183837653 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1838376770 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS183838250 |
CNGA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Achromatopsia 2 |
| RS183839621 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1838416489 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1838431452 |
STXBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1838467288 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS183851663 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Optic atrophy 3, 3-Methylglutaconic aciduria type 3 |
| RS183851734 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ADGRV1-related disorder |
| RS183855575 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS183856964 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1C, TRPM1-related disorder |
| RS183861757 |
ALG6
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG6-congenital disorder of glycosylation 1C, ALG6-related disorder |
| RS183862736 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1838630775 |
CHAT
|
Health Risk |
Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS1838635016 |
CHAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS1838635262 |
CHAT
|
Health Risk |
Pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS183864227 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Spherocytosis |
| RS1838655420 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS183865568 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 1, 3M syndrome 1 |
| RS1838658874 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1838661583 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1838664702 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1838678412 |
MED27
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with spasticity, cataracts |
| RS1838681432 |
ADAM9
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 9, Cone-rod dystrophy |
| RS183868804 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1838729952 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS183873209 |
LMAN1
|
Health Risk |
Likely pathogenic |
Factor V and factor VIII, combined deficiency of |
| RS183877705 |
CCDC22
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS183879985 |
TRPM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS183880522 |
MCPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS183881247 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS183885218 |
TCIRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 1, TCIRG1-related disorder |
| RS183885357 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 4, Nephronophthisis |
| RS1838882266 |
ADAM9
|
Health Risk |
Likely pathogenic |
— |
| RS1838883166 |
CHAT
|
Health Risk |
Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS183890063 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMA2-related muscular dystrophy |
| RS183891852 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Glomerulopathy with fibronectin deposits 2 |
| RS1838926237 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1838929775 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1838935159 |
COL5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1838936100 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |